Prostate cancer recurrence after surgery is nearly double in smokers
the ONA take:
New research points out another cancer prognosis worsened by smoking. This research from an international group of scientists and clinicians from the United States and Europe found that current smokers and those who quit less than 10 years previously are at higher risk of prostate cancer recurrence after surgery.
The group retrospectively reviewed biochemical prostate cancer recurrence in 7,191 men who had undergone radical prostatectomy.
Among the men, approximately one-third each were never smokers, former smokers, and current smokers. After a median follow-up of 28 months, current smokers had approximately double the chance of the cancer recurring. Those who had quit within the last 10 years had a significantly higher risk.
The researchers report that their results confirm what is seen in many other cancers: smoking increases the risk of recurrence after initial treatment.
Furthermore, they recommend that patients stop smoking after a diagnosis of prostate cancer is determined.
Current smokers and those who quit less than 10 years previously are at higher risk of prostate cancer recurrence after surgery.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- Breast Conservation Improves Survival vs Mastectomy in Breast Cancer
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|